Report: Melky Cabrera will not play for the Dominican Republic in the World Baseball Classic

13 Comments

Melky Cabrera was included on the provisional roster for the Dominican Republic when it was announced last month, but he has apparently had a change of heart about participating in the upcoming World Baseball Classic. According to Dionisio Soldevila, a Spanish language reporter for the Associated Press and ESPN Deportes, Cabrera has withdrawn his name from the tournament.

It’s certainly interesting timing, as earlier this week the Miami New Times identified Cabrera as one of the players who allegedly purchased performance-enhancing drugs from the Biogensis clinic in Miami, but it’s not known whether the situation had an impact on his decision. Soldevila’s report merely says that Cabrera wants to spend spring training with the Blue Jays.

Cabrera served a 50-game suspension last season after testing positive for synthetic testosterone. He signed a two-year, $16 million contract with Toronto over the winter and is expected to serve as the club’s starting left fielder this season.

The Tigers decline Anibal Sanchez’s 2018 option

Getty Images
Leave a comment

From the “this does not surprise us in the very least” department, Tigers GM Al Avila announced today that the club is declining its $16 million option on right-hander Anibal Sanchez.

Sanchez had a terrible year in 2017, going 3-7 with a 6.41 ERA in 2017. That’s a long slide down from his 2013 season, in which he won the AL ERA title, going 14-8 and posting an ERA of 2.57 in the first year of his five-year, $80 million deal. Since then he’s gone 28-35 with a 5.15 ERA. He never started 30 games or more over the course of the contract.

The declination of the option does come with a nice parting gift for Sanchez: a $5 million buyout. Which is pretty dang high for a buyout, but that’s how the Tigers rolled three or four years ago.